Precision Biosciences (DTIL) Other Operating Expenses (2022 - 2026)

Precision Biosciences (DTIL) has 5 years of Other Operating Expenses data on file, last reported at $4000.0 in Q1 2026.

• On a quarterly basis, Other Operating Expenses rose 144.44% year-over-year to $4000.0 in Q1 2026; TTM through Mar 2026 was -$408000.0, a 7.37% decrease from a year earlier, with the FY2025 full-year figure at -$421000.0, up 3.44% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $4000.0, up from -$390000.0 in the prior quarter.
• Over the last five years, Other Operating Expenses for DTIL reached as high as $72000.0 in Q2 2023 and fell as low as -$524000.0 in Q4 2023.
• Historically, Other Operating Expenses has averaged -$84000.0 across 5 years, with a median of -$15000.0 in 2022.
• On a YoY basis, Other Operating Expenses climbed as much as 253.19% in 2023 and fell as far as 2657.89% in 2023.
• Year by year, Other Operating Expenses stood at -$19000.0 in 2022, then slumped by 2657.89% to -$524000.0 in 2023, then soared by 65.27% to -$182000.0 in 2024, then slumped by 114.29% to -$390000.0 in 2025, then soared by 101.03% to $4000.0 in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $4000.0 in Q1 2026, -$390000.0 in Q4 2025, and $3000.0 in Q3 2025.